Dr Reddy's Laboratories (Dr Reddy's Laboratories) 5-Year Yield-on-Cost %

: 1.05 (As of Today)

View and export this data going back to 2001. Start your Free Trial

Dr Reddy's Laboratories's yield on cost for the quarter that ended in Dec. 2023 was 1.05.

The historical rank and industry rank for Dr Reddy's Laboratories's 5-Year Yield-on-Cost % or its related term are showing as below:

RDY' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.58 Med: 0.96 Max: 1.56
Current: 1.05

During the past 13 years, Dr Reddy's Laboratories's highest Yield on Cost was 1.56. The lowest was 0.58. And the median was 0.96.

RDY's 5-Year Yield-on-Cost % is ranked worse than
75.7% of 498 companies
in the Drug Manufacturers industry
Industry Median: 2.24 vs RDY: 1.05

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dr Reddy's Laboratories's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Reddy's Laboratories 5-Year Yield-on-Cost % Distribution

For the Drug Manufacturers industry and Healthcare sector, Dr Reddy's Laboratories's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Dr Reddy's Laboratories's 5-Year Yield-on-Cost % falls into.

Dr Reddy's Laboratories 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Dr Reddy's Laboratories is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

Dr Reddy's Laboratories (NYSE:RDY) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Dr Reddy's Laboratories 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (Dr Reddy's Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (NYSE:RDY) » Definitions » 5-Year Yield-on-Cost %

Traded in Other Exchanges

DRREDDY:India 500124:India RDDA:Germany RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.